Bill Commons

IN SB 91

enacted

Syringe exchange program.

Indiana · 2026 Regular Session (2nd Regular Session, 124th General Assembly) · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did IN SB 91 pass?

Yes. IN SB 91 has been enacted into law. Latest recorded action (2026-03-10): Public Law 144

What is IN SB 91 about?

Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.

Who sponsors IN SB 91?

Edward Clere, Brett Clark, Ed Charbonneau and 1 others are the primary sponsors of IN SB 91, joined by 9 cosponsors.

Description

Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.

Introduced
—
Latest action
2026-03-10 — Public Law 144
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Edward Cleresponsor
  • Brett Clarkauthor
  • Ed Charbonneauauthor
  • Michael Criderauthor
  • Lonnie Randolphcoauthor
  • Victoria Garcia Wilburncosponsor
  • Mike Bohacekcoauthor
  • Kyle Walkercoauthor
  • Shelli Yodercoauthor
  • La Keisha Jacksoncoauthor
  • Alex Zimmermancosponsor
  • Ethan Lawsoncosponsor
  • Rodney Polcoauthor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-03-10

    Public Law 144

    became-law

  2. 2026-03-10

    Bill Became Law on 8th Day Without Signature

  3. 2026-02-27

    Signed by the President Pro Tempore

    passage

  4. 2026-02-27

    Signed by the Speaker

    passage

  5. 2026-02-27

    Signed by the President of the Senate

    passage

  6. 2026-02-25

    Senate concurred with House amendments; Roll Call 273: yeas 38, nays 10

  7. 2026-02-19

    Returned to the Senate with amendments

    receipt

  8. 2026-02-19

    Motion to concur filed

    filing

  9. 2026-02-18

    Third reading: passed; Roll Call 271: yeas 70, nays 22

    passage,reading-3,reading-3

  10. 2026-02-17

    Amendment #11 (Mayfield) prevailed; voice vote

    amendment-passage

  11. 2026-02-17

    Second reading: amended, ordered engrossed

    reading-2

  12. 2026-02-17

    Representatives Zimmerman, Garcia Wilburn added as cosponsors

  13. 2026-02-17

    Amendment #14 (Clere) prevailed; voice vote

    amendment-passage

  14. 2026-02-17

    Amendment #12 (Ireland) prevailed; voice vote

    amendment-passage

  15. 2026-02-10

    Committee report: amend do pass, adopted

    committee-passage

  16. 2026-01-29

    First reading: referred to Committee on Public Health

    reading-1,referral-committee

  17. 2026-01-28

    Referred to the House

    referral

  18. 2026-01-28

    Representative Goss-Reaves removed as cosponsor

  19. 2026-01-27

    Cosponsors: Representatives Lawson, Goss-Reaves

  20. 2026-01-27

    Third reading: passed; Roll Call 93: yeas 33, nays 13

    passage,reading-3,reading-3

  21. 2026-01-27

    House sponsor: Representative Clere

  22. 2026-01-27

    Senator Pol added as coauthor

  23. 2026-01-26

    Second reading: amended, ordered engrossed

    reading-2

  24. 2026-01-26

    Amendment #2 (Crider) prevailed; voice vote

    amendment-passage

  25. 2026-01-20

    Senator Randolph added as coauthor

  26. 2026-01-13

    Senators Bohacek, Jackson L added as coauthors

  27. 2026-01-12

    Senator Walker K added as coauthor

  28. 2026-01-08

    Senator Charbonneau added as second author

  29. 2026-01-08

    Committee report: do pass, adopted

    committee-passage

  30. 2026-01-08

    Senator Clark added as third author

  31. 2026-01-08

    Senator Yoder added as coauthor

  32. 2025-12-09

    Authored by Senator Crider

  33. 2025-12-09

    First reading: referred to Committee on Health and Provider Services

    reading-1,referral-committee

Versions

Documents

Votes

  • SB 91 - Crider - 3rd Reading

    2026-01-27 · pass · 33-13

    Member-level votes (49)
    • Alexander: yes
    • Clark: yes
    • Jackson, L: yes
    • Rogers: yes
    • Alting: yes
    • Crider: yes
    • Leising: yes
    • Spencer: yes
    • Bassler: yes
    • Deery: yes
    • Maxwell: yes
    • Taylor: yes
    • Bohacek: yes
    • Dernulc: yes
    • Mishler: yes
    • Walker G: yes
    • Bray: yes
    • Donato: yes
    • Niemeyer: yes
    • Walker K: yes
    • Buchanan: yes
    • Doriot: yes
    • Niezgodski: yes
    • Yoder: yes
    • Buck: yes
    • Glick: yes
    • Pol: yes
    • Busch: yes
    • Holdman: yes
    • Qaddoura: yes
    • Charbonneau: yes
    • Hunley: yes
    • Randolph: yes
    • Baldwin: no
    • Freeman: no
    • Koch: no
    • Young: no
    • Brown: no
    • Gaskill: no
    • Raatz: no
    • Byrne: no
    • Goode: no
    • Schmitt: no
    • Carrasco: no
    • Johnson: no
    • Tomes: no
    • Becker: excused
    • Ford J.D.: excused
    • Garten: excused
  • SB 91 - Clere - 3rd Reading

    2026-02-18 · pass · 70-22

    Member-level votes (100)
    • Abbott: yes
    • Errington: yes
    • Klinker: yes
    • Pierce, K: yes
    • Andrade: yes
    • Garcia Wilburn: yes
    • Lawson: yes
    • Pierce, M: yes
    • Aylesworth: yes
    • Genda: yes
    • Ledbetter: yes
    • Porter: yes
    • Barrett: yes
    • GiaQuinta: yes
    • Lopez: yes
    • Pressel: yes
    • Bartels: yes
    • Gore: yes
    • Manning: yes
    • Pryor: yes
    • Bartlett: yes
    • Goss-Reaves: yes
    • May: yes
    • Shackleford: yes
    • Bauer: yes
    • Hall: yes
    • McGuire: yes
    • Slager: yes
    • Burton: yes
    • Hamilton: yes
    • McNamara: yes
    • Smaltz: yes
    • Campbell: yes
    • Harris: yes
    • Meltzer: yes
    • Smith, V: yes
    • Carbaugh: yes
    • Heaton: yes
    • Miller, K: yes
    • Soliday: yes
    • Cash: yes
    • Heine: yes
    • Moseley: yes
    • Steuerwald: yes
    • Clere: yes
    • Ireland: yes
    • Novak: yes
    • Summers: yes
    • Commons: yes
    • Isa: yes
    • O'Brien: yes
    • Teshka: yes
    • Dant Chesser: yes
    • Jackson, C: yes
    • Olthoff: yes
    • Thompson: yes
    • DeLaney: yes
    • Johnson, B: yes
    • Pack: yes
    • Yocum: yes
    • DeVon: yes
    • Judy: yes
    • Patterson: yes
    • Zimmerman: yes
    • Dvorak: yes
    • Karickhoff: yes
    • Payne: yes
    • Engleman: yes
    • King: yes
    • Pfaff: yes
    • Baird: no
    • Greene: no
    • Lindauer: no
    • Snow: no
    • Bascom: no
    • Haggard: no
    • Mayfield: no
    • Sweet: no
    • Borders: no
    • Hostettler: no
    • Prescott: no
    • VanNatter: no
    • Criswell: no
    • Jeter: no
    • Rowray: no
    • Wesco: no
    • Culp: no
    • Jordan: no
    • Shonkwiler: no
    • Davis: no
    • Lauer: no
    • Smith, H: no
    • Behning: excused
    • Lehman: excused
    • Miller, D: excused
    • Morris: excused
    • Hatcher: excused
    • Lucas: excused
    • Moed: excused
    • Mr. Speaker: not voting
  • SB 91 - Crider

    2026-02-25 · pass · 38-10

    Member-level votes (50)
    • Alexander: yes
    • Busch: yes
    • Glick: yes
    • Randolph: yes
    • Alting: yes
    • Carrasco: yes
    • Holdman: yes
    • Rogers: yes
    • Baldwin: yes
    • Charbonneau: yes
    • Hunley: yes
    • Spencer: yes
    • Bassler: yes
    • Clark: yes
    • Jackson, L: yes
    • Taylor: yes
    • Becker: yes
    • Crider: yes
    • Leising: yes
    • Walker G: yes
    • Bohacek: yes
    • Deery: yes
    • Maxwell: yes
    • Walker K: yes
    • Bray: yes
    • Dernulc: yes
    • Mishler: yes
    • Yoder: yes
    • Brown: yes
    • Donato: yes
    • Niemeyer: yes
    • Young: yes
    • Buchanan: yes
    • Ford J.D.: yes
    • Niezgodski: yes
    • Buck: yes
    • Freeman: yes
    • Qaddoura: yes
    • Byrne: no
    • Goode: no
    • McKinley: no
    • Tomes: no
    • Garten: no
    • Johnson: no
    • Raatz: no
    • Gaskill: no
    • Koch: no
    • Schmitt: no
    • Pol: excused
    • Doriot: not voting

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:09.317128Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=IN&identifier=SB 91. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.